SEC Form D private-offering filing

Everest Biolabs, Inc.

Name: Everest Biolabs, Inc. - new SEC Form D private-offering filing, Waltham, MA
Published: 2026-03-11

A new SEC Form D private-offering notice from Waltham, MA, a $5,650,000 filer-stated offering target in Biotech. The source filing is one click away.

Everest Biolabs, Inc. site↗ Verified via SEC Form D

Develops automated instruments and consumables for extracellular vesicle (EV) and exosome isolation and analysis, including the Ascent and Summit platforms, Apex chromatography columns, and Atlas ELISA kits.

Filed 2026-03-11Filed to raise $5,650,000First money in 2026-02-25Raised so far $4,350,000HQ (as filed) Waltham, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified everestbiolabs.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.